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We report on the largest metagenomic analysis of the pig gut microbiome to date. By 16	
processing over 800 faecal time-series samples from 126 piglets and 42 sows, we generated 17	
over 8Tbp of metagenomic shotgun sequence data. Here we describe the animal trial 18	
procedures, the generation of our metagenomic dataset and the analysis of the microbial 19	
community composition using a phylogenetic framework. We assess the effects of 20	
intramuscular antibiotic treatment and probiotic oral treatment on the diversity of gut 21	
microbial communities. We found differences between individual hosts such as breed, litter, 22	
and age, to be important contributors to variation in the community composition. Treatment 23	
effects of the antibiotic and probiotic treatments were found but were subtle, while host age 24	
was the dominant factor in shaping the gut microbiota of piglets after weaning. The post-25	
weaning pig gut microbiome appears to follow a highly structured developmental program 26	
with characteristic post-weaning changes that can distinguish hosts that were born as little as 27	
two days apart in the second month of life.  28	
 29	
INTRODUCTION  30	
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As the world population grows, there is an accompanying demand for animal derived 31	
products. In a semi-natural environment pig weaning occurs between the 12th and the 17th 32	
weeks from birth, whereas in the farm this typically occurs at 4 weeks of age1. Intensive 33	
animal husbandry and early weaning practices are commonly used to maximise production 34	
rates while minimizing costs. Both practices increase the risk of infections with pathogenic 35	
organisms, and thereby the need for antimicrobial strategies, which has included the common 36	
use of antibiotics. 2–12 Although antibiotics may kill some pathogens, the surviving bacteria 37	
can develop antimicrobial resistance (AMR) against the class of antibiotic used 13–20, as well 38	
as against other antibiotic classes 21–31. A retrospective U.S. livestock study found evidence 39	
of multidrug resistance (resistance to >3 antimicrobial drug classes) in Escherichia coli that 40	
increased from 7.2% to 63.6% between the 1950s and the 2000s 32. As the incidence of 41	
multidrug resistant (MDR) pathogens expands, the World Health Organization (WHO) has 42	
recognized AMR as one of the top health challenges of the current century 33,34.   43	
Besides leading to AMR development, antibiotic usage is known to cause dysbiosis 34–37, 44	
the disruption of a balanced state within a gut microbial community. A balanced state 45	
decreases the chance of pathogens gaining a foothold, as there is niche and nutrient 46	
competition in play 39,40. In livestock production, intramuscular (IM) antibiotic treatment is 47	
preferred over oral antibiotic treatment, as it is thought to contribute less to AMR than oral 48	
antibiotic treatment 41–43. Extensive evidence exists on dysbiosis as a consequence of oral 49	
antibiotic treatment on the gut microbiome 22,35–38,44,45, whereas only a handful of studies 50	
report the effects of intramuscular (IM) antibiotic treatment on the gut microbial community 51	
46–48, and none, to our knowledge have studied the use of IM neomycin treatment.  52	
A number of non-antibiotic strategies to increase resistance to disease have been studied 53	
49. Strategies for which beneficial effects have been reported consist of hydrolases 50, fiber 54	
intake 51, β-lactamase enzymes 52, non-resistance inducing antimicrobial drugs 53,54, 55	
vaccination 55–58, phage therapy 59, in-feed organic acids 60, starches 61, and liquid feed 62–64. 56	
Extensive evidence exists on the use of probiotics. Probiotics are reported to promote 57	
intestinal health in multiple ways: improvement of mucosal integrity 65–68, competitive 58	
exclusion against pathogenic species 50,69–73, reduction of intestinal inflammation 65,74,75  and of 59	
pathogen translocation 65,76,77. Their efficacy has been determined, among others, in cell 60	
cultures 70,74,75,78, mice 50,67,68,73, and swine 65,66,74,76,79–83. However, while most evidence of 61	
beneficial effects from probiotic treatment is derived from host immunity responses 65–68,74–62	
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76,80, host physiology 74,80–82, and pathogen relocation 50,65,69,70,72,77–79,84, fewer studies exist on 63	
the effects of probiotics on the whole gut microbial community 83,85.  64	
This study was conducted to: 1) generate a public metagenomic databank of the gut 65	
microbiome of weaner piglets aged between 3 and 9 weeks old; 2) assess the effects of IM 66	
neomycin antibiotic use on the gut community; and 3) assess the effects of two probiotic 67	
formulations on the gut community. The data we present here is analysed from the 68	
perspective of the phylogenetic diversity of the microbial communities.  69	
In the first results section we describe the phylogenetic diversity of the intestinal 70	
microbiome of the piglets and how it compares to the known composition of positive 71	
controls. Then, we describe evidence that highlights the importance of age, breed and litter 72	
as strongly associated factors with changes in community composition. Lastly, we describe 73	
the strong effect of time on community composition and the milder effect of antibiotic and 74	
probiotic treatments on community composition.  75	
  76	
METHODS 77	
Pig trial  78	
Animal studies were conducted at the Elizabeth Macarthur Agricultural Institute (EMAI) 79	
NSW, Australia and were approved by the EMAI Ethics Committee (Approval M16/04). The 80	
trial animals comprised 4-week old male weaner pigs (n=126) derived from a commercial 81	
swine farm and transferred to the study facility in January 2017. These were cross-bred 82	
animals of Landrace, Duroc and Large White breeds and had been weaned at approximately 83	
3 weeks of age. 84	
The pig facility consisted of four environmentally controlled rooms (Rooms 1-4) with 85	
air conditioning, concrete slatted block flooring with underground drainage and open rung 86	
steel pens (S1). Each room had nine pens, consisting of a set of six and a set of three pens, 87	
designated a-f and g-i respectively, with the two sets of pens being physically separate, i.e. 88	
animals could come in contact with each other through the pen’s bars within each set of 89	
pens, but not between sets. The rooms were physically separated by concrete walls and 90	
contamination between rooms was minimized by using separate equipment (boots, gloves, 91	
coveralls) for each room. In addition, under-floor drainage was flushed twice weekly and the 92	
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flushed faeces/urine was retained in under-floor channels that ran the length of the facility, 93	
so that Rooms 1, 2 were separate from Rooms 3, 4 and flushing was in the direction 1 to 2 94	
and 3 to 4.  95	
The pigs were fed ad libitum a commercial pig grower mix of 17.95% protein free of 96	
antibiotics, via self-feeders. On the day of arrival (day 1) 30, 18, 18, and 60 pigs were 97	
allocated randomly to Rooms 1, 2, 3 and 4 respectively in groups of 6, 6, 6 and 6-7 pigs per 98	
pen respectively (S1A). Pigs were initially weighed on day 2, and some pigs were moved 99	
between pens to achieve an initial mean pig weight per treatment of approximately 6.5 kg 100	
(range: 6.48-6.70; mean±SD: 6.53±0.08). Pigs were weighed weekly throughout the trial 101	
(Supplementary file 1). Behaviour and faecal consistency scores were taken daily over the 102	
6-week period of the trial (Supplementary file 2). Developmental and commercial probiotic 103	
paste preparations ColiGuard® and D-Scour™ from International Animal Health, 104	
Australasia, were used in some treatment groups.  105	
The animals were acclimatised for 2 days before the following treatments were 106	
administered: Room 1 - oral 1 g/pig of placebo paste daily for 14 d; Room 2 - oral 1 g/pig of 107	
D-Scour™ paste daily for 14 d; Room 3 - oral 1 g/pig of ColiGuard® paste daily for 14 d; 108	
Room 4 - intramuscular (IM) injection of antibiotic administered at 0.1 mL per pig daily 109	
from a 200 mg/mL solution for a total treatment duration of 5 d.  110	
On the day following the final neomycin treatment (day 8), 36 pigs were moved from 111	
Room 4 to Room 2 (n=18, 6 in each pen, pens g-i), and to Room 3 (n=18, 6 in each pen, pens 112	
g-i) (S1). The following day (day 9), oral administration of D-Scour™ (1 g/pig) and of 113	
ColiGuard® (1 g/pig) commenced for pigs in Room 2 pens g-i and in Room 3 pens g-i, 114	
respectively, and continued for a period of 14 days. Assignment of the 36 neomycin-treated 115	
pigs to the treatment groups neomycin+D-Scour™ (n=18; Room 2 pens g-i) and 116	
neomycin+ColiGuard® (n=18; Room 3 pens g-i), was carried out by distributing them so 117	
that the mean weight of the animals distributed across pens and rooms was similar 118	
(Supplementary file 1). By this time point, each occupied pen in the trial housed six pigs. 119	
(S1B) From that time, twelve piglets from the original 126 were no longer present, as they 120	
had been euthanised as pre-treatment controls at the start of the trial.  121	
Faecal samples were collected from all piglets once per week and from a subset (n=48 122	
pigs; 8 from each of the six cohorts) twice per week over the 6-week study period (Figure 123	
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1). From each piglet, faeces were collected per rectum with new disposable gloves; where 124	
minimal or no faeces could be collected on a collection day, sampling was performed the 125	
following morning. Samples were placed in 50 mL Falcon tubes and stored at 4oC within 30 126	
mins of sample collection for a minimum of 30 mins and a maximum period of 6 h.   127	
Faecal sample processing 128	
Samples (3g/pig) were mixed with 15 mL PBS (200 mg/mL), in sterile stomacher bags 129	
and homogenized with a Bio-Rad stomacher. The homogenised samples were divided in 130	
replicates: one replicate was stored directly at -80oC and one replicate was supplemented 131	
with glycerol (20% v/v) (Sigma-Aldrich) then stored at -80o C. In addition, single time-point 132	
faecal samples from the dams of the trial pigs (n=42) were obtained from the commercial 133	
facility of origin and were pre-processed at EMAI as described above. Thus, a total of 911 134	
unique samples, between one and ten samples per subject (mean: 4.8; median: 3) (S2), were 135	
obtained throughout this study. At the end of the trial period, all samples were transported 136	
from EMAI to the University of Technology Sydney (UTS) for further processing.  137	
Positive controls 138	
As a positive control “mock community” for this study, four Gram positive (Bacillus 139	
subtilis strain 168, Enterococcus faecium, Staphylococcus aureus ATCC25923, 140	
Staphylococcus epidermidis ATCC35983) and three Gram negative (Enterobacter 141	
hormaechei CP_032842, Escherchia coli K-12 MG1655, Pseudomonas aeruginosa PAO1) 142	
bacterial strains from -80℃ stocks were cultured at 37oC for 16 h in LB (Luria-Bertani) then 143	
centrifuged at 14,000 rpm for 10 mins. From the resulting pellets, 1 g was transferred to 1 144	
mL of LB and homogenised and a 1:10 dilution of this was made for each bacterial culture. 145	
Ten microliters of bacterial suspension from each of the cultures was used to determine the 146	
number of colony forming units (CFU) in the original suspension in the following manner: 147	
by further diluting tenfold in LB and by plating onto 1.6% LB agar plates and incubacted 148	
overnight. The remaining suspensions (990 μL from each bacterial culture) were pooled into 149	
a sterile tube, then aliquoted into Eppendorf tubes in 500 μL volumes/tube. As a washing 150	
step, Eppendorf tubes were centrifuged at 14,000 rpm for 10 mins, 500 μL PBS was added to 151	
the pellet and subsequently resuspended. These tubes constituted the mock community 152	
samples and were stored at -80oC. Expected proportions of the mock community members 153	
were determined from the estimated colony forming units (CFU) multiplied by the genome 154	
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size and were as follows: 8.7:13.0:7.7:16.7:38.9:14.5:0.4 for S. aureus, B. subtilis, E. 155	
faecium, S. epidermidis, P. aeruginosa, E. cloacae, and E.coli respectively.  156	
The two probiotic formulations used in this study were used as two additional positive 157	
controls. D-Scour™ is a commercially available probiotic formulation for livestock, with 158	
each gram containing 180 million CFU of the following: Lactobacillus acidophilus, 159	
Lactobacillus delbrueckii subspecies bulgaricus, Lactobacillus plantarum, Lactobacillus 160	
rhamnosus, Bifidobacterium bifidum, Enterococcus faecium, Streptococcus salivarius 161	
subspecies thermophilus, with an additional 20 mg of garlic extract (Allium sativum). The 162	
probiotic ColiGuard is a probiotic formulation developed for the treatment of entero-163	
toxigenic Escherichia coli (ETEC) in weaner pigs, developed in collaboration between the 164	
NSW DPI and International Animal Health Products, containing undefined concentrations of 165	
Lactobacillus plantarum and Lactobacillus salivarius. 166	
DNA extraction   167	
Piglet and sow faecal samples, mock community samples, negative controls and 168	
probiotic samples (D-Scour™ and ColiGuard® paste) were allocated to a randomized block 169	
design to control for batch effects in DNA extraction and library preparation. The faecal 170	
samples were thawed on ice first, followed by the probiotics and mock community samples. 171	
MetaPolyzyme (Sigma-Aldrich) treatment was performed according to the manufacturer’s 172	
instructions except for the dilution factor, which we allowed to be 4.6 times higher. 173	
Immediately after incubation, DNA extraction was performed with the MagAttract 174	
PowerMicrobiome DNA/RNA EP kit (Qiagen) according to the manufacturer’s instructions. 175	
Quantification of DNA was performed using PicoGreen (Thermofisher) and measurements 176	
were performed with a plate reader (Tecan, Life Sciences) using 50 and 80 gain settings. All 177	
samples were diluted to 10 ng/µL.  178	
Library preparation  179	
Sample index barcode design using a previously introduced method 86 yielded a set of 96 180	
x 8nt sequences with a 0.5 mean GC content and none of the barcodes containing 3 or more 181	
identical bases in a row. Nine hundred-sixty different combinations of i5 and i7 primers were 182	
used to create a uniquely barcoded library for each sample. The detailed sample-to-barcode 183	
assignment is given in Supplementary file 3. Library preparation was carried out using a 184	
modification of the Nextera Flex protocol to produce low bias, low cost shotgun libraries, as 185	
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described in a previous manuscript 86. Following the amplification step, samples were 186	
centrifuged at 280 x g for 1 min and stored between 1 and 5 days at 4°C.  187	
Size selection and purification 188	
Samples from the same 96-well plates were pooled into one tube by taking 5 μL from 189	
each library. This generated 10 pooled samples, one for each plate. A master pool was 190	
created by pooling 5 μL from the pool of each plate into a single pool. Forty microliters from 191	
each of the 10 plate pools and 40 μL from the master pool underwent library size selection 192	
and purification using equal volumes of SPRIselect beads (Beckman Coulter) and ultrapure 193	
water (Invitrogen). Sample cleaning with SPRI-beads was performed as described previously 194	
86. A purified master pool comprising samples from all plates, and purified pools of 195	
individual plates to check for plate-specific anomalies, were diluted to 4 nM and fragment 196	
size distribution was assessed using the High Sensitivity DNA kit on the Bioanalyzer 197	
(Agilent Technologies, USA).  198	
Normalisation and sequencing 199	
The master pool was sequenced on an Illumina MiSeq v2 300 cycle nano flow cell 200	
(Illumina, USA). Read counts were obtained and used to normalise libraries. The liquid 201	
handling robot OT-One (Opentrons) was programmed to re-pool libraries based on read 202	
counts obtained from the previous MiSeq run. The script used to achieve the normalization is 203	
available through our Github repository.  204	
The read count distribution after normalisation is displayed in supplementary figure 205	
(S3). The normalized and purified pooled library was sequenced on an Illumina NovaSeq S4 206	
flow cell at the Ramaciotti Centre for Genomics (Sydney, NSW, Australia), generating a 207	
total of 27 billion read pairs from 911 samples.  208	
Sequence data processing 209	
Adapter trimming (parameters: k=23 hdist=1 tpe tbo mink=11), PhiX DNA removal 210	
(parameters: k=31 hdist=1), and quality filtering (parameters: ftm=0 qtrim=r trimq=20), were 211	
performed using bbduk.sh (http://jgi.doe.gov/data-and-tools/bbtools). Quality assessment of 212	
raw reads was carried out using FASTQC 213	
(http://www.bioinformatics.babraham.ac.uk/projects/fastqc/) and a combined report of all 214	
samples was obtained with MULTIQC 87 (Supplementary File 4). The presence of PCR 215	
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duplicates was assessed by feeding read pairs to dedupe.sh (http://jgi.doe.gov/data-and-216	
tools/bbtools) (parameters: ac=f). Nextflow 88 was used to manage processing of the data on 217	
the HPC.  218	
Determination of microbial diversity among samples  219	
Phylogenetic diversity of all samples was assessed with PhyloSift 89 using the first 100k 220	
read pairs of each sample (parameters: --chunk-size 100000 --paired). In order to test for 221	
associations of phylogenetic diversity with treatment, time of sampling, and differences 222	
among hosts at the start of the trial, analysis of the unrooted phylogenetic diversity (PD) 90, 223	
the balance weighted phylogenetic diversity (BWPD) 91 and principal component analysis 224	
(PCA) of the Kantorovich-Rubinstein distances 92 (beta diversity analysis) were performed. 225	
Alpha-diversity and beta-diversity were analyzed and the results were visualized with R 93 226	
and R packages 91–107. The data analysis is schematically represented in Supplementary 227	
Figure 4 (S4). 228	
Additionally, SortmeRNA 111 (version 2.1) was applied to extract 16S ribosomal RNA 229	
genes from raw reads. The rRNA reference database silva-bac-16s-id90 was used. Hits were 230	
filtered (e-value <= 1e-30) and PCA was computed with R 93. Sample counts were 231	
normalized for library size by proportions and were tested with the Spearman’s Rank 232	
correlation coefficient method to find taxa correlating with the weight of the piglets across 233	
the trial.  234	
Batch effects 235	
A randomized block design was adopted to mitigate batch effects. Because samples 236	
were distributed across ten 96-well plates during DNA extraction and library preparation, 237	
plate effects were expected. Although samples did not visibly cluster by DNA extraction 238	
plate across the first five principal components (S5), a batch effect was found by multiple 239	
comparison analysis with ANOVA and by applying Tukey post-hoc correction to pairwise 240	
comparisons. Batch effects were detected (ANOVA, alpha diversity: p range=4.8e-12-241	
0.00011; beta diversity: p value<0.0023) (S6; Supplementary file 5) and removed with 242	
COMBAT7 (ANOVA p value=1) (S7; Supplementary file 5).  243	
Technical analysis of positive controls  244	
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As a quality control step, taxonomic analysis of the positive control samples and their 245	
technical replicates was performed with MetaPhlAn2 112. The positive controls included the 246	
mock community (n=8), D-Scour™ (n=8), and ColiGuard® (n=8) samples.   247	
Data availability 248	
The raw sequencing data has been submitted to the NCBI Short Read Archive under 249	
project PRJNA526405. Metadata and scripts are available in this article, its Supplementary 250	
material and in our Github repository https://github.com/GaioDany/metapigs_base 251	
 252	
RESULTS  253	
PhyloSift 89 was employed as a means to study microbial community diversity among 254	
the samples, and to test for associations with treatment, time of sampling, and differences 255	
among hosts at the start of the trial. To this end, analysis of the unrooted phylogenetic 256	
diversity (PD) 90, the balance weighted phylogenetic diversity (BWPD) 91 and principal 257	
component analysis (PCA) of the Kantorovich-Rubinstein distances 92 (beta diversity 258	
analysis) were performed. 259	
Comparison of the expected and the observed taxonomic profile of the positive controls  260	
All the mock community members, in seven of the eight technical replicates, were 261	
detected by MetaPhlAn2 (S8). One sample failed to sequence, reporting zero counts for any 262	
species. The observed mean relative abundances were as follows: B. subtilis (mean±SD: 263	
2.92±0.994), E. cloacae (mean±SD: 38.0±6.404), E. faecium (mean±SD: 0.97±0.081), E.coli 264	
(mean±SD: 10.12±1.480), E.coli unclassified (mean±SD: 7.83± 1.755), P. aeruginosa 265	
(mean±SD: 26.72±3.026), S. aureus (mean±SD: 9.90±3.613), S. epidermidis (mean±SD: 266	
3.54±1.435). Isolate E. cloacae C15117, used in this study for the make-up of the mock 267	
community, was recently found to be most closely related to the Enterobacter hormaechei 268	
phylogenomic group C type strain DSM 16687 and therefore re-identified as Enterobacter 269	
hormaechei subsp. oharae113 . For this reason, taxonomic assignment by MetaPhlAn2 270	
attributed the reads to E. cloacae instead. The expected proportions of the mock community 271	
members were derived from the CFU by the genome size. Based on the expected and the 272	
observed relative abundance, we found, with the exception of S. aureus (exp: 8.7% obs: 273	
9.9%), three Gram positive members to be under-represented (B. subtilis: exp: 13.0% obs: 274	
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2.9%; E. faecium: exp: 7.7% obs: 1.0%; S. epidermidis: exp: 16.7% obs: 3.5%) and, with the 275	
exception of P. aeruginosa (exp: 38.9% obs: 26.8%), two Gram negative members to be 276	
over-represented (E. cloacae: exp: 14.5% obs: 38.0%; E.coli: exp: 0.4% obs: 7.8-10.1%) 277	
(S9). Taxonomic assignment of the mock community samples reported one contaminating 278	
species in one of the eight replicates: Lactobacillus salivarius (mean: 0.008) (S10).  279	
The probiotic D-Scour™ is expected to contain, per gram, a total of 180 million CFU of 280	
Lactobacillus acidophilus, Lactobacillus delbrueckii subspecies bulgaricus, Lactobacillus 281	
plantarum, Lactobacillus rhamnosus, Bifidobacterium bifidum, Enterococcus faecium, 282	
Streptococcus salivarius subspecies thermophilus in unknown proportions. From taxonomic 283	
analysis with MetaPhlAn2, we can conclude that 6 of the 7 expected species were 284	
determined to be present in the replicates in the following mean relative abundances: 285	
Bifidobacterium bifidum: mean±SD: 40.01±12.558; Enterococcus faecium: mean±SD: 286	
30.98±13.472; Lactobacillus delbrueckii: mean±SD: 11.56±7.148; Lactobacillus plantarum: 287	
mean±SD: 6.23±7.863; Lactobacillus rhamnosus: mean±SD: 2.08±1.226; Streptococcus 288	
thermophilus: mean±SD: 4.28±1.523. Lactobacillus acidophilus was not detected and 289	
Lactobacillus helveticus was detected instead (Lactobacillus helveticus: mean±SD: 290	
4.75±2.431) (S8). An additional 25 taxa were detected, of which 18 and 7 were identified at 291	
the species and at the genus level, respectively. Contaminants were present at a higher 292	
concentration in three technical replicates (R3, R7, R8) with the most frequent contaminant 293	
(Methanobrevibacter spp.) being present in 5 of the 8 replicates (S11).  294	
Taxonomic analysis of the technical replicates of the probiotic ColiGuard® also showed 295	
a species profile consistent with the expected profile, with Lactobacillus salivarius and 296	
Lactobacillus plantarum in a 9:1 ratio (Lactobacillus salivarius: mean±SD: 93.52±1.617; 297	
Lactobacillus plantarum: mean±SD: 6.10±1.134) across the replicates (S8). ColiGuard® 298	
contained a total of 20 contaminants, of which 16 and 4 were identified at the species and the 299	
genus level, respectively. Contaminants were present at a higher level in two technical 300	
replicates (R5, R7), with R7 displaying the most diverse and highest contamination rate (R7: 301	
14 taxa; total contaminating reads: 2.67%; R5: 9 taxa; total contaminating reads: 0.30%). 302	
(S12).  303	
Phylogenetic diversity of positive controls and how it compares to the taxonomic profile 304	
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Alpha diversity of the positive controls reflects the expected alpha diversity, with the 305	
mock community, ColiGuard® and D-Scour™ positive controls, displaying a progressively 306	
higher unrooted PD (mean±SD: Mock community: 31.53±29.50; ColiGuard®: 58.52±21.70; 307	
D-Scour™: 64.84±21.30). BWPD for the positive control ColiGuard® appears on the far left 308	
of the plot (mean±SD: 0.82±0.15), distant from the mock community (mean±SD: 1.58±0.12) 309	
and the positive control D-Scour™ (mean±SD: 1.89±0.26), which contains 2, 7 and 8 main 310	
species, respectively (S13; Supplementary file 1). The unrooted PD of the positive control 311	
ColiGuard® (mean±SD: 58.52±21.70) is closer to the unrooted PD of the Mock Community 312	
(mean±SD: 31.53±29.50) and to that of the positive control D-Scour™ (mean±SD: 313	
64.84±21.30), than the BWPD.  314	
The contribution to total diversity of phylogenetic tree edges with uneven quantities of 315	
reads placed on either side is down-weighted in BWPD, which is reflected in the low 316	
reported BWPD of the positive control ColiGuard®. ColiGuard® is mainly composed of two 317	
species in an uneven ratio (1:9) as by taxonomic analysis with MetaPhlAn2 (S8), in contrast 318	
with the mock community (0.01:1:3:4:8:10:10:27:38) and the positive control D-Scour™ 319	
(2.08:4.28:4.75:6.23:11.56:30.98:40.01) (S8). On the other hand, the unrooted PD reflects 320	
the absolute diversity, independently of the relative abundance of each species, within a 321	
sample. In fact, low-level contamination (<0.1%) detected in each of the positive controls 322	
(Mock Community: 1 taxon; ColiGuard®: 20 taxa; D-Scour™: 25 taxa) (S11-13) contributes 323	
toward the absolute diversity in the unrooted PD, erroneously inflating this value (mean±SD: 324	
Mock Community: 31.53±29.50; ColiGuard®: 58.52±21.70; D-Scour™: 64.84±21.30) 325	
(Figure 2).  326	
Phylogenetic diversity of piglet gut communities immediately after weaning 327	
The 126 piglets used in this study were derived from 4 main breed cross types “Duroc × 328	
Landrace” (n=46), “Duroc × Large White” (n=59), “Landrace × cross bred (LWxD)” (n=9), 329	
“Large White × Duroc” (n=12), and three pig lines (line 319: n=9; line 316: n=46; line 326: 330	
n=71). The piglets also differed slightly by age, being born between 1 and 6 days apart. 331	
Based on Kruskal-Wallis one-way analysis of variance (Hommel adjusted p values to 332	
correct for multiple testing), phylogenetic diversity of the piglet samples did not cluster 333	
significantly by breed cross type (p > 0.05) or by pig line (p > 0.05) at the start of the trial, 334	
but a significant difference was found with breed and line in the fourth week of the trial 335	
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(breed: p=0.04; pig line: p=0.02) (Figure 2). Additionally a correlation of breed cross type 336	
was found with beta diversity principal components (PC) in the second week of the trial 337	
(PC3: p=0.0357) and in the fifth week of the trial (PC1: p=0.027). Alpha diversity 338	
significantly correlated with pig line in the fourth week of the trial (BWPD: p=0.017). 339	
(Figure 2; Supplementary file 5) 340	
Notably, we found a significant correlation between alpha diversity and the age of the 341	
piglets at the first sampling time point (unrooted PD: p=0.0016; BWPD: p=0.0355) (Figure 342	
2; Supplementary file 5). While a correlation with age was found for alpha diversity only at 343	
the start of the trial, age of the piglet was observed to be weakly associated with differences 344	
in community composition in week two (PC3: p=0.0507) (S14; Supplementary file 5).  345	
As age groups were confounded with cross-breed types (i.e. not all age groups are 346	
represented by each of the four cross-breed types), we compared the phylogenetic diversity 347	
of age groups within each breed. As cross-breed types “Landrace × cross bred (LW × D)” 348	
and “Large White × Duroc” had only a small number of piglets in each age group, we tested 349	
for an association between phylogenetic diversity and age in cross-breeds “Duroc × 350	
Landrace” and “Duroc × Large White”. In these cross-breeds, alpha and beta diversity are 351	
correlated with age in the “Duroc × Landrace” piglets (unrooted PD: p=0.0059; BWPD: 352	
p=0.0226; PC2: p=0.0263; PC5: p=0.0063) and to a lesser extent in the “Duroc × Large 353	
White” piglets (unrooted PD: p=0.0529; PC5: p=0.0310) during the first week of the trial. In 354	
the “Duroc × Landrace” piglets, a correlation between age and beta diversity was detected in 355	
week two (PC2: p=0.0347) (Figure 2; S14; Supplementary file 5). Differences in beta 356	
diversity by date of birth, within the same cross-breed (Duroc × Large white), were found to 357	
be significant (TukeyHSD adjusted p value: 1 day difference: 0.000782; 2 days difference: 358	
0.018603) (Supplementary file 5). 359	
Maternal effect on phylogenetic diversity 360	
As piglets were derived from 42 distinct sows (maternal sows), and nursed by either the 361	
same or a different sow (a nurse sow) (Supplementary File 5), a litter effect was expected 362	
and determined. Based on Hommel adjusted p values, a similarity of alpha and beta 363	
phylogenetic diversity can be seen among piglets from the same maternal sow (unrooted PD: 364	
p=0.0096; BWPD: p=0.0467) and in piglets from the same nurse sow (unrooted PD: 365	
p=0.0320; PC1: p=0.0391) (Figure 2; S16-19; Supplementary file 5). The litter effect 366	
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described was found in samples at the start of the trial. Significance of the correlations did 367	
not persist thereafter (Figure 2; Supplementary file 5).  368	
A strong effect of aging on phylogenetic diversity  369	
Beta diversity analysis revealed a distinct and consistent change of the microbial 370	
community over time in all piglets, regardless of the treatment. Samples clustered in PC2 371	
(accounting for 21.68% of the variation), showing a higher representation of Bacteroidetes, 372	
Gammaproteobacteria and Prevotellaceae from day 0-20, and a higher representation of 373	
Firmicutes, Mollicutes and Ruminococcaceae from day 20-40 (Figure 3; S20). In PC1 374	
(accounting for 46.99% of the variation) samples shifted towards a higher representation of 375	
Lactobacilli from day 0 to day 20, and towards a higher representation of Actinobacteria, 376	
Clostridiales and Mollicutes from day 20 to day 40 (Figure 3; Supplementary file 5). A 377	
temporary shift towards a higher representation of Bifidobacteriaceae (Bifidobacterium 378	
being a component of the probiotic D-Scour™) is seen in PC5 (3.04% of the variation 379	
explained) one and two weeks from the start of the trial (S21).  380	
Beta diversity analysis was performed separately for samples within each time point in 381	
order to find taxa associated with variation within each time point. Extent of variation was 382	
derived from the product of branch width by the variation explained by the principal 383	
component (S22). The following taxa were responsible for variation only at the start of the 384	
trial: Gammaproteobacteria (t0=0.12), Enterobacteriaceae (t0=0.08) and Archaea (t0=0.03). 385	
The following taxa were responsible for variation throughout the trial: Clostridiales 386	
(min=0.11; max=0.25), Bacteroidetes (min=0.06; max=0.11), Bacteroidetes chlorobi group 387	
(min=0.05; max=0.10). Lactobacillus became variable after the first week of the trial and 388	
remained highly variable throughout the trial (min=0.13; max=0.22). Some taxa contributed 389	
less to the variability among the piglets’ faecal population, but they nonetheless consistently 390	
contributed to variability: Bacteroidales (min=0.01; max=0.04); Firmicutes (min=0.05; 391	
max=0.08); Bacilli (min=0.06; max=0.09); Lactobacillales (min=0.04; max=0.08); 392	
Actinobacteria (min=0.02; max=0.09); Proteobacteria (min=0.02; max=0.07). The 393	
variability of Prevotella (min=0.01; max=0.04) increased from the second week of the trial. 394	
(S22)  395	
Taxonomic representation in terms of abundance was derived from analysis of samples 396	
with guppy fat, where abundance was derived from the branch width (Figure 4) and 397	
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combined with PhyloSift’s taxonomic annotation of the marker gene phylogeny. Overall, 398	
Clostridiales were the most abundant throughout the trial (t0=0.18; t2=0.20; t4=0.11; 399	
t6=0.09; t8=0.10; t10=0.08). Lactobacillus acidophilus increased at the start (t0=0.00; 400	
t2=0.05; t4=0.13) then decreased (t6=0.09; t8=0.05; t10=0.07). Subdoligranulum variabile 401	
decreased after the first week (t0=0.05; t2=0.02) then gradually increased (t4=0.04; t6=0.05; 402	
t8=0.06; t10=0.07). Among other prevalent taxa at the start of the trial up to the second week 403	
and dropping at later time points we found Metahobrevibacter smithii (t0=0.06; t2=0.03) and 404	
Bacteroidales (t0=0.02; t2=0.01). Following an opposite trend we found Ruminococcus sp. 405	
JC304 (t0=0.00; t2=0.00; t4=0.01; t6=0.02; t8=0.02; t10=0.03), Solobacterium moorei 406	
(t0=0.00; t2=0.01; t4=0.02; t6=0.02; t8=0.02; t10=0.02) and Prevotella copri (t0=0.00; 407	
t2=0.00; t4=0.04; t6=0.03; t8=0.05; t10=0.02). In modest and stable abundance across the 408	
trial were Mogibacterium sp. CM50 (t0=0.02; t2=0.03; t4=0.02; t6=0.03; t8=0.02; t10=0.04) 409	
and Oscillibacter (t0=0.06; t2=0.04; t4=0.03; t6=0.03; t8=0.03; t10=0.03). In transient 410	
abundance we found Bifidobacterium thermophilum RBL67 (t2=0.01; t4=0.02). Gradually 411	
increasing from the second week we found Eubacterium biforme DSM3989 (t2=0.01; 412	
t4=0.02; t6=0.02; t8=0.02; t10=0.02), Eubacterium rectale (t4=0.02; t6=0.02; t8=0.03; 413	
t10=0.01) and, after the third week, Faecalibacterium prausnitsii (t6=0.01; t8=0.02; 414	
t10=0.02).  415	
The effect of time was also clear in alpha diversity, where all the piglet cohorts followed 416	
a similar trend over time, independent of the treatment (S23; Supplementary file 5). Upon 417	
arrival on the trial site, the piglets’ unrooted PD was lower than the sows (sows: 125.39; 418	
piglets range: 104.6-112.7) and reached a similar unrooted PD to the sows’ in the second 419	
week (range: 123.4-130.7) (Supplementary file 5). 420	
In comparing four timepoints at one week intervals from the start of the trial (intervals 421	
labeled as A, B, C, D), changes in alpha diversity among all the piglets were tested for and 422	
significance was determined using the Bonferroni correction. Unrooted phylogenetic 423	
diversity increased after the start of the trial (A mean: 107.86; B mean: 127.21; p<0.001), 424	
decreased in the following week (C mean: 122.92; p=ns) and the fourth week (D mean: 425	
118.74; p=ns) amongst the piglets cohorts. In contrast, BWPD decreased after the start of the 426	
trial (A mean: 2.17; B mean: 2.05; p<0.0001), to increase in the following week (C mean: 427	
2.14; p<0.0001) and decrease in the fourth week (D mean: 2.07; p<0.01). (S23; 428	
Supplementary file 5). The increase in unrooted PD in the first week was significant for all 429	
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treatment cohorts (p range: 0.0015-0.03) except ColiGuard® and neomycin (p=ns) cohorts. 430	
The decrease in BWPD in the first week was only significant for the control (p=0.04), 431	
ColiGuard® (p=0.0015) and neomycin+ColiGuard® (p=0.036) cohorts. In week two only 432	
the increase of BWPD of the control cohort reached statistical significance (p=0.0121). (S24; 433	
Supplementary file 5)  434	
Effect of antibiotic and probiotic treatment on alpha diversity 435	
We hypothesized that the probiotic treatments, whether alone (D-Scour™ and 436	
ColiGuard®) or administered after neomycin (neomycin+D-Scour™ and 437	
neomycin+ColiGuard®) would cause a change in the microbial community composition that 438	
would be measurable via phylogenetic diversity. We tested whether the treatments correlated 439	
with a change in phylogenetic diversity independently of the changes occurring with 440	
time. Given the differences in alpha and beta diversity detected among the subjects at the 441	
start of the trial, we analyzed the deltas of phylogenetic diversity instead of relying on the 442	
absolute means, similar to the procedure applied by Kembel et al (2012) 114. Time-point 443	
measurements of alpha diversity were taken and deltas were computed for each piglet. Delta 444	
means were compared between cohorts, where the control cohort would serve as a control 445	
group for neomycin, D-Scour™ and ColiGuard® cohorts, whereas the neomycin cohort 446	
would serve as a control group for the neomycin+D-Scour™ and neomycin+ColiGuard® 447	
cohorts.  448	
After the first week of the trial, the majority of the piglets displayed an increase in 449	
unrooted PD (85%) and a decrease of BWPD (75%). The following week the trend was 450	
opposite: an increase of BWPD (78%) and a decrease of unrooted PD (60%) 451	
(Supplementary file 5). However, the neomycin cohort displayed the smallest BWPD drop 452	
in the week following the start of the trial and the overall trend of neomycin in unrooted PD 453	
was the most different from the other cohorts (S25). Due to the delayed rise in unrooted PD 454	
of neomycin, significance was found in unrooted PD between neomycin and neomycin+D-455	
Scour™ during the first week of D-Scour™ treatment (neomycin mean: 1.59; neomycin+D-456	
Scour™ mean: -11.79; p= 0.012188) (S25 B-C) and in unrooted PD between neomycin and 457	
neomycin+ColiGuard® (neomycin mean: -5.53; neomycin+ColiGuard®: -6.70; p=0.043138) 458	
(S25 C-D). The change was opposite in BWPD (p=0.049263) (S26 B-C) and persisted 459	
during the following week, up to 3 days post- D-Scour™ treatment (neomycin mean: -6.34; 460	
neomycin+D-Scour™ mean: 4.52; BH adjusted p=0.024092) (S26 B-D).  461	
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The only significant difference between the neomycin and the control cohort was 462	
detected in BWPD in the second week of the trial (control mean: 7.10; neomycin mean: 463	
0.28) p=0.033751) (S26 B-C).  464	
No significant differences were detected between the control and the D-Scour™ cohort 465	
(p<0.05) (Supplementary file 5). Instead, a significant decrease in BWPD was detected in 466	
the ColiGuard® cohort between the start of the trial and the end of the ColiGuard® 467	
treatment, where nearly all piglets (88%) in the ColiGuard® cohort displayed a decrease in 468	
BWPD, whereas the control cohort was split between piglets increasing (53%) and 469	
decreasing (47%) in BWPD (control mean: 0.85; ColiGuard® mean: -5.49; p=0.040041) 470	
(S26 A-C).  471	
Effects of antibiotic and probiotic treatment on beta diversity 472	
To investigate the treatment effect on beta diversity, principal component analysis 473	
(PCA) of the Kantorovich-Rubenstein distances (beta diversity analysis) was performed on 474	
all samples and, additionally, on samples within individual time points. This analysis is 475	
conceptually similar to the weighted Unifrac approach for beta diversity analysis, but is 476	
designed to work with phylogenetic placement data 92. When examining all samples together, 477	
there was no clear separation of cohorts on any of the five principal component axes. When 478	
individual time points were analysed, some clustering by cohort was observed (S27). D-479	
Scour™ separated from the control cohort in PC2 (17.95%) and in PC3 (8.06%) one week 480	
and two weeks after probiotic treatment, respectively (S27). ColiGuard® separated from 481	
control two weeks post probiotic treatment in PC3 (7.88%). Two weeks after the end of 482	
neomycin treatment, neomycin separated from control in PC4 (5.32%), with a smaller 483	
clustering and a higher representation of Mollicutes. Two and four weeks after probiotic 484	
treatment, neomycin+D-Scour™ separated from neomycin in PC2 (17.74%) and PC5 485	
(3.81%), respectively. In both timepoints and principal components, neomycin+D-Scour™ 486	
showed a higher representation of Lactobacillales. (S27)  487	
Association between weight and community composition 488	
Weight correlated with the abundance of certain species (n=83) at each time point as it 489	
resulted from principal component analysis of 16S rRNA reads. Positively correlating with 490	
weight we found among others: Blautia (t0), Cetobacterium (t0), Ruminibacter (t0), 491	
Rickettsia (t2), Lactobacillus (t6), Mycoplasma (t6), Anaerostipes (t8), Ruminococcus (t8-492	
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t10), Cerasibacillus (t10). Negatively correlating with weight we found among others: 493	
Pyramidobacter (t0), Odoribacter (t2), Schwartzia (t6), Streptococcus (t6), Dokdonella (t8). 494	
(S28-S33) Significance values and correlation estimates are given in Supplementary file 5.  495	
Effect of treatments on weight gain 496	
Overall weight gain from initial to final weight (S34 A-E; Supplementary file 5) was 497	
not significantly affected by any treatment. However, the probiotic ColiGuard® was found to 498	
have a partial effect on piglet weight gain (S34; Supplementary file 5). Weight was 499	
measured weekly for a total of six measurements. Based on Tukey adjusted p values, a lower 500	
weight gain was detected in the ColiGuard® cohort in week 3 compared to the control cohort 501	
(p=0.0008) (S34 C-D; Supplementary file 5). Similarly, a lower weight gain was detected 502	
in the neomycin+ColiGuard® cohort in C-E compared to the neomycin cohort (p=0.0393) 503	
(S34 C-E; Supplementary file 5). Breed and age differences among piglets were not 504	
associated with weight gain (Supplementary file 5). 505	
 506	
DISCUSSION 507	
The consistent trend in community composition over time, across all the cohorts, 508	
indicates that an age-related process of ecological succession is the largest factor shaping the 509	
microbial community of post-weaning piglets, as found in this study where animals aged 20-510	
63 days and were fed the same diet. A peak in unrooted phylogenetic diversity and drop in 511	
balance weighted phylogenetic diversity (BWPD) reflects the acquisition of new species 512	
with the loss of dominating species. This change, detected in the week following the piglets’ 513	
arrival at the trial site irrespective of the cohort, could be linked to the piglets being 514	
subjected to microbial interchange (e.g.: new pen mates 115,116) and/or to diet transition (peri-515	
weaning transition to solid food 115,116) leading to the reshaping of the gut microbial 516	
community. The week following the drop of BWPD, a significant increase of BWPD was 517	
recorded, reflecting the acquisition of a larger proportion of the community by the newly 518	
introduced species. The strong changes in phylogenetic diversity detected in the first and the 519	
second week could as well be attributable to other post-weaning related physiological 520	
changes, as previous studies report 44,115–117.  521	
The highest inter-individual differences among piglets are seen in the first week of life, 522	
irrespective of maternal or environmental effects. The microbiota of 3 week old piglets is 523	
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still very dynamic, but environmental factors become evident 116. At 6 weeks of age, CD8+ T 524	
cells infiltrate the intestinal tissue and the mucosa and intestinal lining resemble that of an 525	
adult pig 115 . In this study, piglets reached a comparable alpha diversity to the sows after the 526	
first week of the trial, at which time the piglets were aged between 3.8 and 4.6 weeks. 527	
Unrooted PD did not reach higher levels at later sampling time points. The highest BWPD 528	
accompanied by a high unrooted PD was reached after the second week of the trial when 529	
piglets were aged between 4.9 and 5.6 weeks. Age-dependent physiological changes could 530	
explain i) the major shifts we detected in alpha diversity during the first two weeks of the 531	
trial and, ii) the distinct differences in community composition with age, even with a narrow 532	
age difference between piglets (1-6 days). We were able to appreciate a significant trend of 533	
increasing unrooted PD and decreasing BWPD with age in piglets that separated a 6 days 534	
maximum by day of birth from each other. Since age groups were confounded with breeds in 535	
our study, we attempted to determine the correlation within single breeds. Unfortunately, 536	
although the correlations with age could still be detected, we could not determine the 537	
association at later time points due to the introduction of treatment effects.		538	
Animal trials are often conducted in controlled environments so as to minimize 539	
environmental effects. However, individual variations such as breed and age are often 540	
unavoidable in large animal trials. Previously reported confounding factors include: 541	
individual variation 44, cohabitation 115,116, age 44,115,116, maternal effects 115,116,118, hormones 44, 542	
behavioural differences between breeds (e.g. coprophagy, mouth to mouth contact) and 543	
extent of long-term behavioural adaptation, which can differ between breeds for reasons not 544	
attributable to genetics 44,115,116. A litter effect was found in piglets at the start of the trial and 545	
was lost at later time points during the trial. This could be due to either of the 546	
aforementioned factors. Co-housing, aging and the splitting of the piglets in separate rooms 547	
to receive a different treatment, are possible causes for loss of the litter effect. In this study 548	
we confirm the importance of these factors in the contribution to inter-individual variability 549	
of gut microbial composition. Motta et al (2019) report a correlation of beta diversity with 550	
age and no correlation of genotype and litter effect with either alpha or beta diversity 9 . On 551	
the contrary, we found the piglet samples to significantly cluster by litter, breed and by age 552	
up to the second and the fourth week post weaning, in alpha diversity and beta diversity, 553	
respectively. We conclude that even small age differences among post- weaning piglets, 554	
down to the day, must be accounted	for	in	an	experimental	set	up. 555	
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Three	 groups	 of	 piglets (cohorts neomycin, neomycin+D-Scour™ and 556	
neomycin+ColiGuard®) underwent 5 days of treatment with the broad-spectrum antibiotic 557	
neomycin, via intramuscular administration. Intramuscular neomycin poorly diffuses (<10%) 558	
into a healthy gastrointestinal tract 119 , therefore a direct effect of neomycin on the gut 559	
microbiome may not be expected. However, neomycin showed a different trend in unrooted 560	
PD between the second and the third week of the trial, corresponding to the week following 561	
the neomycin treatment period for the neomycin cohort. Taking this time frame into 562	
consideration, the neomycin cohort did not increase in BWPD to the extent of the Control 563	
cohort. Although statistically significant differences between neomycin and Control in alpha 564	
diversity were not reached, the BWPD of the neomycin cohort appears to follow a different 565	
trend to the Control from the first week (during neomycin treatment) where neomycin treated 566	
piglets show the lowest decrease of BWPD compared to the control cohort and all other 567	
cohorts. While all cohorts show an increase in absolute phylogenetic diversity accompanied 568	
by a decrease of diversity evenness during this time frame, the neomycin cohort piglets show 569	
a lower drop in BWPD, suggesting an increase of species richness, without a corresponding 570	
loss of species evenness. Furthermore the neomycin cohort significantly separated from the 571	
control cohort in beta diversity in the third week of the trial, showing a higher representation 572	
of Mollicutes. Numerous studies report the link of oral antibiotic use with dysbiosis 22,35–573	
38,44,45, as well as with host physiology changes 37. On the contrary, the effect of intramuscular 574	
antibiotic administration on the microbiome is less well investigated. Correlation between 575	
intramuscular antibiotic use and dysbiosis has been reported in fish 46, gorillas 47, humans 120, 576	
and pigs 48,121. In 1 day old piglets, a single IM injection of amoxicillin (penicillin class) is 577	
reported to have an effect on the intestinal microbiota, detectable 40 days post treatment 48. 578	
Zeineldin et al (2018) tested the effects of IM administration of several antibiotics of various 579	
classes (penicillin, macrolide, cephalosporin and tetracycline), in 8-week old piglets, 580	
reporting shifts of the Firmicutes/Bacteroidetes ratio following treatment (length of the 581	
treatment not reported)121. The effects of intramuscular administration of neomycin 582	
(aminoglycoside class) on the gut microbiota have to our knowledge not been investigated. 583	
Based on our results we conclude that a mild effect on phylogenetic diversity is appreciable 584	
post IM neomycin treatment, up to two weeks after termination of the treatment. Additional 585	
compositional and functional analysis is necessary to determine the source of this mild 586	
variation. Differences were not detected at later time points, based on our phylogenetic 587	
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diversity analyses, suggesting a full recovery of the microbial communities after two week 588	
from the end of the treatment.  589	
It is possible that the large shifts in phylogenetic diversity taking place in the first two 590	
weeks irrespective of the treatment (an increase, then decrease of unrooted PD, and an 591	
opposite trend of BWPD) have masked the milder effects of the treatment, despite our efforts 592	
to control for the effects of aging. This could be the reason why a significantly distinct alpha 593	
diversity trend was found in the neomycin+D-Scour™ cohort compared to the neomycin 594	
cohort, but not in the D-Scour™ cohort compared to the Control cohort. The neomycin+D-595	
Scour™ cohort underwent 5 days of neomycin treatment followed by 2 weeks of D-Scour™ 596	
treatment. A significant increase of BWPD was detected in the two-week period of D-597	
Scour™ treatment, indicating a possible enhancement of microbiome evenness following 598	
neomycin treatment. To our knowledge there are no studies reporting an increased evenness 599	
in piglet gut community composition following a specific probiotic treatment. There are 600	
instead multiple studies reporting beneficial effects of probiotic treatment in sucker and 601	
weaner piglets in terms of improved gut mucosal integrity 66,80, growth rate 80–83, digestibility 602	
of proteins and water absorption 80,83, reduction of pathogen invasion efficiency 76,79,80, and 603	
decreased mortality 80,82. Although the assessment of physiologic changes from probiotic 604	
treatments was outside the scope of this study, we found significant separation of 605	
neomycin+D-Scour™ cohort samples to neomycin cohort samples in beta diversity 3 and 10 606	
days after D-Scour™ treatment, where neomycin+D-Scour™ samples showed a higher 607	
representation of Lactobacillales compared to neomycin samples, suggesting a transient 608	
establishment of the probiotic strains in the piglet guts.  609	
The second probiotic in this study, ColiGuard®, did not have an effect on alpha 610	
diversity, but clustering was detected in beta diversity, where ColiGuard® samples separated 611	
from Control cohort samples in the third principal component (explaining 7.88% of the 612	
variation) two weeks post probiotic treatment. Additionally, the ColiGuard® treatment 613	
correlated with a lower weight gain, whether or not it was preceded by the antibiotic 614	
treatment. However, when comparing the overall weight gain (from the start to the end of the 615	
trial) the weight gain in the cohorts receiving ColiGuard® did not differ from the other 616	
cohorts.  617	
We extracted the 16S rRNA gene hypervariable regions from our dataset, obtained the 618	
counts, and ran a correlation analysis to discover taxa that correlated with the weight of the 619	
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piglets. As a consequence of the library size normalization step, the use of correlation with 620	
compositional data can inflate the false discovery rate 122,123. For this reason it can be 621	
expected that some of the taxa we found to correlate with the weight of the piglets (eighty-622	
three distinct species) could be spurious while other correlations may have been missed.  623	
Technical controls in metagenomic studies and methodological limitations 624	
Taxonomic assignment of the raw reads from the positive controls was performed with 625	
MetaPhlAn2112 which relies on a ca. 1M unique clade-specific markers derived from 17,000 626	
reference genomes. Such a database to map against the positive controls suffices as these 627	
organisms are cultivable, and for this reason they are widely studied hence the sequences are 628	
known. This is not the case for real-world samples where mapping against a database (which 629	
completeness relies on studied and often cultivable organisms) would narrow the view on the 630	
true diversity within the sample.   631	
Positive controls with well-studied members and known ratios within the samples, has 632	
proven to be a valuable tool to assess consistency among technical replicates across batches 633	
and to detect possible biases derived from the DNA extraction method.  634	
Systematic taxonomic bias in microbiome studies, resulting from differences in cell wall 635	
structures between Gram positive and Gram negative bacteria, have previously been 636	
reported; sample treatment with enzymatic cocktails can modestly reduce this bias 124–126. 637	
Although we implemented this step in our workflow, it seems that, from the read abundance 638	
of our mock community, which contained three Gram negative and four Gram positive 639	
strains, a bias towards Gram negative taxa may still be present.  640	
In terms of contamination we concluded that: a) contamination in our study was not 641	
batch specific; b) a problem of sample cross-contamination existed at the DNA extraction 642	
step between neighbouring wells. During the bead beating step of DNA extraction, the deep-643	
well plate is sealed with a sealing mat, rotated and placed in a plate shaker for the bead 644	
beating to take place. We consider that sample cross-contamination is most likely to occur 645	
during this step.  646	
 647	
Conclusion 648	
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Our study provides a publicly-available databank of the pig gut metagenome. Our findings 649	
further stress the importance of confounding factors such as breed, age and maternal effects 650	
when assessing the effect of treatment on the gut microbiome. We found that age, even 651	
within a narrow age span (1-6 days) can have an impact on microbial shifts and should be 652	
accounted for in microbiome studies. Intramuscular neomycin treatment correlated with a 653	
clustering in alpha diversity and a higher representation of Mollicutes compared to control. 654	
D-Scour™ treated piglets displayed a mild shift in alpha diversity compared to control, and a 655	
transient establishment of Lactobacillales. ColiGuard® treated piglets displayed a clustering 656	
in beta diversity and a transient lower weight gain compared to control. Weight correlated 657	
with the abundance of a number of taxa. Age was the strongest factor shaping phylogenetic 658	
diversity of the piglets.  659	
As previously mentioned, phylogenetic diversity is based on distinct taxa (richness) and 660	
their collective structure (proportions reflected by BWPD) and not on a direct assessment of 661	
composition and function. These types of analyses will be necessary to further describe the 662	
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Figure 1. Timeline. 
Timeline of the trial indicating the start and the length of the treatment for each cohort. 
Piglets  arrived on the site  of  the trial  on January 30th and were allowed 2 days of 
acclimatisation before the start of the treatments (pink: placebo paste; yellow: probiotic 
D-Scour™  formulation;  green:  probiotic  ColiGuard®  formulation;  blue:  antibiotic 
neomycin intramuscular injection). Vertical lines indicate main days of sampling where 
all piglets where sampled (n=126). Small arrows indicate days of sampling for a subset 
of the piglets (8 per cohort; n=48). 
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Figure 2. Significance of correlations between phylogenetic diversity and specified factors. 
Plots of p values derived from Kruskal-Wallis analysis of variance (black) and adjusted p values by 
Benjamini-Hochberg method (red).  x-axis  displays distinct  sampling time points  in chronological 
order. Correlation of specified factors of samples are shown with (A) alpha diversity and (B) beta 
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Figure 3. Effect of time on beta diversity.
Principal component analysis (PCA) of samples. PCA from edge component analysis with PhyloSift (top) 
and PCA from 20 most abundant 16S reads extracted with SortMeRNA (bottom). In the top, distribution 
of samples on either side of the plot (left versus right; top versus bottom) reflect the taxa that were found 
to explain the variation. Samples are colour coded by days into the trial. In the lower plot, arrows indicate 
which of the 20 taxa read contributed to the variation of samples, where arrows thickness represents a 
higher (thicker) or lower (thinner) contribution. Samples are colour coded by time point during the trial. 
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Figure 4. Abundance heatmap.
Most abundant taxa within each time point are obtained from analysis with guppy fat. Abundance is 
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Supplementary Figure 1. Piglets placements across rooms and pens. 
Disposition of piglets in rooms (1-4) and pens (a-i) at the start of the trial (A) and re-
arrangement of a subset of neomycin treated piglets from room 4 to room 2 and room 
3, for D-Scour™ and ColiGuard® treatment, respectively (B). 
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Supplementary Figure 2. Sample collection. 
Samples were collected from all piglets once weekly, and from a subset group (8	per	cohort;	n=48)	 
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Supplementary Figure 3. Read counts distribution. 
Read counts distribution of all samples (main histogram) and low read counts samples (top 
right histogram). 
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Supplementary  Figure  5.  Principal  component  analysis  of  batch  effect  before  batch  effect 
removal. 
Principal  components  1  to  4  from beta  diversity  analysis  of  all  samples  before  batch  effect 
removal.  Samples  are  coloured  by  DNA extraction  plate.  No  clustering  of  samples  by  DNA 
extraction plate is visible. 
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Supplementary Figure 6. Batch effect on alpha and beta diversity before batch effect removal.
 
Batch effect by alpha (top two plots) and beta diversity (bottom five plots) before batch effect 
removal. Samples are grouped by DNA extraction plate. The p values are derived from multiple 
comparison analysis with ANOVA, indicating equality of the means. Post hoc corrected p values 
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Supplementary Figure 7. Batch effect on alpha and beta diversity after batch effect removal. 
Batch effect by alpha (top two plots) and beta diversity (bottom five plots) after batch effect removal. 
Samples are grouped by DNA extraction plate.  The p values are derived from multiple comparison 
analysis  with  ANOVA,  indicating  equality  of  the  means.  Post  hoc  corrected  p  values  for  pairwise 
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Supplementary Figure 8. Taxonomic assignment of reads from positive control samples. 
Taxonomic profile of the positive controls used in this study obtained by mapping the reads against a 
~1M  bacterial  genomes  database  with  MetaPhlAn2.  Each  stacked  barplot  represents  a  technical 
replicate. Taxa of which reads are present in >0.1% are displayed. A. In-house made mock community; 
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Supplementary Figure 9. Expected and observed relative abundance of mock community members. 
Expected relative abundance is derived by multiplying CFU count by genome size. Observed relative 
abundance is derived by multiplying reads mapping with MetaPhlAn2. A higher observed/expected 
ratio is observed in two of the three Gram negative species and a lower observed/expected ratio is 
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Supplementary Figure 10. Contamination rate in mock community samples. 
Heatmap  of  contaminating  species  present  in  the  positive  control  mock  community  technical 
replicates. Lactobacillus salivarius is found in one replicate at 0.01% of the total reads. 
Mock community contamination
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Supplementary Figure 11. Contamination rate in D-Scour™ samples. 
Heatmap of contaminating species present in the positive control D-Scour™ technical replicates. 
The D-Scour™ technical replicates contained 25 contaminants, of which 18 and 7 were identified at the 
species and at genus level, respectively. Contaminants are majorly present in three technical replicates 
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Supplementary Figure 12. Contamination rate in ColiGuard® samples. 
Heatmap of contaminating species present in the positive control ColiGuard® technical replicates. 
ColiGuard® contained 20 contaminants, of which 16 and 4 were identified at the species and at genus 
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Supplementary Figure 13. Alpha phylogenetic diversity of cohorts. 
Alpha phylogenetic diversity per cohort from samples across all time points. Phylogenetic entropy (top); 
Balance-weighted  phylogenetic  diversity  (BWPD)  (mean±SD:  Positive  control  Mock  community: 
1.58±0.12; Positive control D-Scour™: 1.89±0.26; Positive control ColiGuard®: 0.82±0.15; Control:
2.12±0.14;  D-Scour™:  2.14±0.14;  ColiGuard®:  2.11±0.13;  neomycin:  2.12±0.17;  neomycin+D-
Scour™: 2.12±0.14; neomycin+ColiGuard®: 2.10±0.15; sows: 2.13±0.14; all piglet cohorts: 2.12±0.14); 
(middle);  Unrooted phylogenetic diversity (Positive control  Mock community:  31.53±29.50; Positive 
control  D-Scour™:  64.84±21.30;  Positive  control  ColiGuard®:  58.52±21.70;  Control:  117±16.8;  D-
Scour™:  121±14.7;  ColiGuard®:  118±22.3;  neomycin:  119±22.6;  neomycin+D-Scour™:  116±23.4; 
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Supplementary Figure 14. Alpha phylogenetic diversity by age group. 
Alpha diversity  of  samples  from the start  of  the trial  grouped by the date  of  birth  of  the piglet. 
Unrooted phylogenetic diversity (top) and balance weighted phylogenetic diversity (bottom). P values 
are derived from Kruskal-Wallis analysis of variance. Pairwise comparisons and post hoc corrected p 
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Supplementary Figure 15. Alpha phylogenetic diversity by age breed. 
Alpha diversity of samples from the start of the trial grouped by breed and by date of birth. Unrooted 
phylogenetic diversity (top) and balance weighted phylogenetic diversity (bottom). P values are derived 
from Kruskal-Wallis analysis of variance. Pairwise comparisons and post hoc corrected p values are 
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Supplementary Figure 16. Unrooted alpha phylogenetic diversity by maternal and nurse sow. 
Alpha phylogenetic diversity (unrooted) of samples from piglets at the start of the trial (one time point 
-sample per piglet). The grouping is based on the maternal sow (A) or nurse sow (B). P values from 
multiple groups comparison by maternal sow: Kruskal-Wallis p values: 0.0011; BWPD: 0.0049. P 
values from multiple groups comparison by nurse sow: Kruskal-Wallis  p values:  0.0036; BWPD: 
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Supplementary Figure 17. Balance weighted alpha phylogenetic diversity by maternal and nurse 
sow. 
Alpha phylogenetic diversity (unrooted) of samples from piglets at the start of the trial (one time 
point -sample per piglet). The grouping is based on the maternal sow (A) or nurse sow (B). P values 
from multiple groups comparison by maternal sow: Kruskal-Wallis p=0.0049. P values from multiple 
groups  comparison  by  nurse  sow:  Kruskal-Wallis  p=0.0071.  Post-hoc  pairwise  comparisons  and 
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Supplementary Figure 18. Principal component analysis of piglet samples by nurse sow. 
First  two principal  components  of  beta  phylogenetic  diversity.  Principal  component  1  (PC1) and 
principal component 2 (PC2) explaining 46.99% and 21.68%  of the variation, respectively. 
Samples from piglets at the start of the trial (one time point -sample per piglet) coloured by nurse sow 
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Supplementary Figure 19. Principal component analysis of piglet samples by maternal sow. 
First two principal components of beta phylogenetic diversity. Principal component 1 (PC1) and 
principal component 2 (PC2) explaining 46.99% and 21.68%  of the variation, respectively. 
Samples  from piglets  at  the  start  of  the  trial  (one time point  -sample  per  piglet)  colored by 
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Supplementary Figure 20. Time effect on beta diversity per cohort.  
Edge principal component analysis of all samples coloured by sample collection time across the trial 
(day 0: red; day 10: yellow; day 20: green; day 30: light blue; day 40: dark blue) where principal 
component  1 (PC1) explains  46.99% of  the variation and principal  component  2 (PC2) explains 
21.68% of the variation. Each plot displays all samples within each cohort. 
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Supplementary Figure 21. Time effect on beta diversity. 
Each plot represents the samples distribution along one of the five principal components across time. 
Most variation is explained by PC1 (46.99%), followed by PC2 (21.68%), PC3 (8.37%), PC4 (5.1%) and 
PC5 (3.04%). Distribution of the samples on either side of a plot (left versus right) reflects the taxa that 
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Supplementary Figure 22. Taxa displaying the highest variation in beta diversity across time. 
Heatmap of taxa explaining the community composition of samples from separate time points of the 
trial  (1  week  interval  between  time  points)  derived  from  edge  principal  component  analysis. 
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Supplementary Figure 23. Time trend of alpha diversity by cohort. 
Unrooted  PD  (A)  and  BWPD  (B)  describe  richness  and  evenness,  respectively,  of  alpha 
phylogenetic  diversity  for  all  samples  across  time,  grouped and colour  coded by cohort.  The p 
values derived from pairwise comparisons of time points within each of the cohorts. P values and 
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Supplementary Figure 24 Alpha diversity by cohort across four time points. 
Alpha phylogenetic diversity for each cohort for a subset of 4 time points. P values are derived from 
pairwise comparisons of the means of each time point of (A) unrooted phylogenetic diversity and (B) 
balance weighted phylogenetic diversity. Bonferroni correction of p values is applied. More time points 
were tested and significance was determined; reported in Supplementary File 5. 
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Supplementary Figure 25. Deltas of unrooted alpha phylogenetic diversity between time points. 
Change of alpha unrooted phylogenetic diversity in samples between time points across the trial. On 
the y-axis of plots the percentage difference in unrooted PD between time points per cohort. Letters on 
the top left of each plot indicate the time points compared with one week interval (A-B, B-C, C-D, D-
E) and two weeks interval (A-C, B-D). Pairwise t-test comparisons between cohorts were computed. 
Brackets in the timeline (top) indicate a significant p value (p<0.05) between cohorts (1-week interval); 
bold brackets indicate a significant p value (p<0.05) between cohorts (2-weeks interval). * indicate 
significance reached when applying Benjamini-Hochberg post-hoc correction. 
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Supplementary Figure 26. Deltas of balance weighted alpha phylogenetic diversity between time points. 
Change of alpha balance weighted phylogenetic diversity in samples between time points across the trial. 
On the y-axis of plots the percentage difference in balance weighted phylogenetic diversity between time 
points per cohort. Letters on the top left of each plot indicate the time points compared with one week 
interval (A-B, B-C, C-D, D-E) and two weeks interval (A-C, B-D). Pairwise t-test comparisons between 
cohorts were computed. Brackets in the timeline (top) indicate a significant p value (p<0.05) between 
cohorts (1-week interval); bold brackets indicate a significant p value (p<0.05) between cohorts (2-weeks 
interval). * indicate significance reached when applying Benjamini-Hochberg post-hoc correction. 
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Supplementary Figure 27. Significant differences in beta diversity between cohorts at specific time 
points.
 
Significance was determined by comparing groups by pairwise t-test and the resulting p values where 
adjusted with the Bonferroni method. Significance values are provided in Supplementary File 5. The x-
axes represent the principal component. As plots are derived from distinct guppy runs, each principal 
component explains variation to a different extent (percentage specified in parentheses). The number of 
samples is specified on the y-axis. Distribution of the samples on either side of a plot (left versus right) 
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Supplementary Figure 28. Correlation of weight with taxonomy at time point 0. 
16S rRNA reads  were  extracted with  SortMeRNA. Abundance was estimated and correlation with 
weight was assessed with the Spearman method. Significance values are provided in Supplementary 
File 5. Plotted are the correlations with p value < 0.05. For visualization purposes, subjects are binned 
into weight groups (x-axis). Bins are formed with subjects whose weight falls below the first quartile 
(red), above the first quartile (green), below the third quartile (blue), above the third quartile (purple). 
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Supplementary Figure 29. Correlation of weight with taxonomy at time point 2. 
16S rRNA reads  were  extracted with  SortMeRNA. Abundance was estimated and correlation with 
weight was assessed with the Spearman method. Significance values are provided in Supplementary 
File 5. Plotted are the correlations with p value < 0.05. For visualization purposes, subjects are binned 
into weight groups (x-axis). Bins are formed with subjects whose weight falls below the first quartile 
(red), above the first quartile (green), below the third quartile (blue), above the third quartile (purple). 
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Supplementary Figure 30. Correlation of weight with taxonomy at time point 4. 
16S rRNA reads  were  extracted with  SortMeRNA. Abundance was estimated and correlation with 
weight was assessed with the Spearman method. Significance values are provided in Supplementary 
File 5. Plotted are the correlations with p value < 0.05. For visualization purposes, subjects are binned 
into weight groups (x-axis). Bins are formed with subjects whose weight falls below the first quartile 
(red), above the first quartile (green), below the third quartile (blue), above the third quartile (purple). 
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Supplementary Figure 31. Correlation of weight with taxonomy at time point 6. 
16S rRNA reads  were  extracted with  SortMeRNA. Abundance was estimated and correlation with 
weight was assessed with the Spearman method. Significance values are provided in Supplementary 
File 5. Plotted are the correlations with p value < 0.05. For visualization purposes, subjects are binned 
into weight groups (x-axis). Bins are formed with subjects whose weight falls below the first quartile 
(red), above the first quartile (green), below the third quartile (blue), above the third quartile (purple). 
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Supplementary Figure 32. Correlation of weight with taxonomy at time point 8. 
16S rRNA reads  were  extracted with  SortMeRNA. Abundance was estimated and correlation with 
weight was assessed with the Spearman method. Significance values are provided in Supplementary 
File 5. Plotted are the correlations with p value < 0.05. For visualization purposes, subjects are binned 
into weight groups (x-axis). Bins are formed with subjects whose weight falls below the first quartile 
(red), above the first quartile (green), below the third quartile (blue), above the third quartile (purple). 
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Supplementary Figure 33. Correlation of weight with taxonomy at time point 10. 
16S rRNA reads  were  extracted with  SortMeRNA. Abundance was estimated and correlation with 
weight was assessed with the Spearman method. Significance values are provided in Supplementary 
File 5. Plotted are the correlations with p value < 0.05. For visualization purposes, subjects are binned 
into weight groups (x-axis). Bins are formed with subjects whose weight falls below the first quartile 
(red), above the first quartile (green), below the third quartile (blue), above the third quartile (purple). 
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Supplementary Figure 34. Weight gain of piglets by cohort across the trial. 
On the y-axis of plots the weight gain between time points is provided in percentage. Letters on the top 
left of each plot indicate the time points compared with one week interval (A-B, B-C, C-D, D-E) and 
with two weeks interval (B-D, C-E, A-E). Pairwise t-test comparisons between cohorts were computed. 
Brackets in the timeline (top) indicate a significant p value between cohorts (1-week interval); bold 
brackets indicate a significant p value between cohorts (2-weeks interval). A significant difference was 
found  between  Control  and  ColiGuard®  (C-D,  Tukey  adjusted  p  value=0.000747)  and  between 
neomycin  and  neomycin+ColiGuard®  (C-E,  Tukey  adjusted  p  value=0.039286).  *in  the  timeline 
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